Correlation Between HCW Biologics and Centessa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on HCW Biologics and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Centessa Pharmaceuticals.
Diversification Opportunities for HCW Biologics and Centessa Pharmaceuticals
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between HCW and Centessa is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of HCW Biologics i.e., HCW Biologics and Centessa Pharmaceuticals go up and down completely randomly.
Pair Corralation between HCW Biologics and Centessa Pharmaceuticals
Given the investment horizon of 90 days HCW Biologics is expected to generate 1.61 times less return on investment than Centessa Pharmaceuticals. In addition to that, HCW Biologics is 3.48 times more volatile than Centessa Pharmaceuticals PLC. It trades about 0.02 of its total potential returns per unit of risk. Centessa Pharmaceuticals PLC is currently generating about 0.09 per unit of volatility. If you would invest 388.00 in Centessa Pharmaceuticals PLC on August 30, 2024 and sell it today you would earn a total of 1,372 from holding Centessa Pharmaceuticals PLC or generate 353.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HCW Biologics vs. Centessa Pharmaceuticals PLC
Performance |
| Timeline |
| HCW Biologics |
| Centessa Pharmaceuticals |
HCW Biologics and Centessa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Centessa Pharmaceuticals
The main advantage of trading using opposite HCW Biologics and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Centessa Pharmaceuticals vs. Ikena Oncology | Centessa Pharmaceuticals vs. Eliem Therapeutics | Centessa Pharmaceuticals vs. HCW Biologics | Centessa Pharmaceuticals vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |